Table 3. Summary of other bevacizumab studies.

Article	Sample size	Dose	Median treatment time	Response
Plotkin et al 8	10 patients	5 mg/kg every 2 weeks	12 months	90% with reduction in tumor size
Plotkin et al 9	31 patients	5 mg/kg every 2 weeks	14 months	Freedom from progression in 88% by 1 year and 67% by 2 years
Alanin et al 10	12 patients	First 6 months: 10 mg/kg every 2 weeks Maintenance: 15 mg/kg every 3 weeks	22 months	Reduction in tumor volume in 88%
Current study	7 patients	First 6 months: 10 mg/kg every 2 weeks Maintenance: 5 mg/kg every 3 weeks	33 months	Freedom from linear and volumetric progression, respectively: 1 year: 90%, 100% 2 years: 79%, 88% 3 years: 53%, 70%